芯能科技(603105.SH):控股股東、實際控制人及其一致行動人之間擬內部轉讓股份
格隆匯5月20日丨芯能科技(603105.SH)公佈,因個人職業規劃需要,公司控股股東和實際控制人之一致行動人的張佳穎擬通過大宗交易的方式將名下所持有的公司1.0000%的股份全部內部轉讓給公司控股股東和實際控制人之一的張文娟。本次內部轉讓股份後,張佳穎將不再持有公司股份。本次轉讓股份為實際控制人及其一致行動人之間的內部轉讓。本次股份轉讓後,公司控股股東和實際控制人未發生變化,仍為張利忠、張文娟、張震豪,三人直接持有並通過法人股東正達經編和乾潮投資間接持有公司股份共190,560,000股,佔公司總股本的38.1120%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.